Clinical Trials for PharmaMar

Explore 10 clinical trials worldwide

Showing 1-10 of 10 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: PharmaMar

Clinical Trials (10)

NCT06766825
Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults with Post-COVID-19 Condition (PCC)
PHASE2Recruiting
90 participants
Started: Feb 7, 2025 · Completed: Jun 1, 2026
5 conditions3 sponsors1 location
NCT06524583
Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour
PHASE2Recruiting
198 participants
Started: Jan 27, 2025 · Completed: Dec 31, 2030
1 condition8 sponsors25 locations
NCT06088290
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)
PHASE3Recruiting
450 participants
Started: Sep 21, 2023 · Completed: Aug 30, 2029
1 condition1 sponsor87 locations
NCT05841563
Clinical Trial of PM54 in Advanced Solid Tumors Patients.
PHASE1Recruiting
125 participants
Started: Apr 28, 2023 · Completed: Apr 30, 2027
1 condition1 sponsor3 locations
NCT05835609
PM534 Administered Intravenously to Patients With Advanced Solid Tumors
PHASE1Recruiting
30 participants
Started: Dec 23, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor3 locations
NCT05153239
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)
PHASE3Active, not recruiting
705 participants
Started: Jul 22, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor210 locations
NCT04383119
Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma
PHASE2Recruiting
100 participants
Started: Oct 29, 2021 · Completed: Dec 31, 2025
2 conditions2 sponsors17 locations
NCT04305548
Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma
PHASE2Recruiting
16 participants
Started: Sep 14, 2021 · Completed: Dec 1, 2025
1 condition2 sponsors7 locations
NCT05101265
Clinical Pharmacokinetic Study of Lurbinectedin in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Impairment
PHASE1Recruiting
24 participants
Started: Mar 9, 2021 · Completed: Jun 1, 2025
2 conditions1 sponsor6 locations
NCT05076396
PM14 Administered Intravenously to Patients with Advanced Solid Tumors
PHASE1Recruiting
150 participants
Started: Sep 6, 2017 · Completed: Aug 13, 2025
1 condition1 sponsor9 locations